3 Depression affects around 1 in 6 adults in the UK at any given time
This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)
While not FDA-approved as a combination, some providers may prescribe these medications together to break plateaus
Magnesium glycinate or citrate Beneficial for gut health, particularly when managing nausea
Keywords: Introduction Diabetic retinopathy (DR) is one of the most common and serious complications of diabetes mellitus (DM) and can lead to blindness in patients (Leasher et al